Remove Compliance Remove Gene Expression Remove Genetics
article thumbnail

Symvivo’s Oral COVID-19 Vaccine Enters Clinical Trials

XTalks

The Burnaby, BC-based company developed the oral DNA-based vaccine using its proprietary bacTRL Gene Therapy Platform, which uses genetically modified bifidobacteria as carriers of genetic vaccine elements on a DNA plasmid. BacTRL Gene Therapy Platform. Related: Red Meat Allergy Test Gets FDA Clearance. “We

article thumbnail

World Glaucoma Week 2024: New Advances in Glaucoma Care

XTalks

These advancements have not only helped improve the precision of glaucoma management but have also considerably improved patient compliance and quality of life. There are also studies examining gene therapy-based techniques to repair or replace genetic defects contributing to this disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma

The Pharma Data

This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. If Amgen fails to meet the compliance obligations in the corporate integrity agreement between Amgen and the U.S. government, Amgen could become subject to significant sanctions.

Trials 52
article thumbnail

Tezepelumab granted Priority Review by U.S. FDA

The Pharma Data

The FDA grants Priority Review to applications for medicines that offer significant advantages over available options by demonstrating safety or efficacy improvements, preventing serious conditions or enhancing patient compliance.(1) Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma.